Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lerch

Showing results (581-590 of 640) with videos related to

Pageof 64
Sort By:
Cell Host & Microbe|August 11, 2019
Obese Individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and CompositionLouise B Thingholm, Malte C Rühlemann, Manja Koch, et al.
Gastroenterology|July 23, 2022
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic PancreatitisUjjwal M Mahajan, Bettina Oehrle, Simon Sirtl, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 7, 2020
International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic ClubWilliam Greenhalf, Philippe Lévy, Thomas Gress, et al.
JAMA|July 12, 2012
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trialJohn P Neoptolemos, Malcolm J Moore, Trevor F Cox, et al.
The American Journal of Gastroenterology|April 22, 2010
Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory processJ-Matthias Löhr, Ralf Faissner, Dirk Koczan, et al.
Gut|December 13, 2012
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysisPhil A Hart, Terumi Kamisawa, William R Brugge, et al.
BMC Gastroenterology|January 17, 2013
Pre-study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitisGabriele Fluhr, Julia Mayerle, Eckhard Weber, et al.
Scientific Reports|January 30, 2019
Variants in ABCG8 and TRAF3 genes confer risk for gallstone disease in admixed Latinos with Mapuche Native American ancestryBernabé I Bustos, Eduardo Pérez-Palma, Stephan Buch, et al.
Cancers|November 27, 2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNAKaren Aughton, Nils O Elander, Anthony Evans, et al.
International Journal of Cancer|August 22, 2012
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinomaAlexander Baraniskin, Stefanie Nöpel-Dünnebacke, Maike Ahrens, et al.
Pageof 64

Showing results (581-590 of 640) with videos related to

Sort By:
Pageof 64
Cell Host & Microbe|August 11, 2019
Obese Individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and CompositionLouise B Thingholm, Malte C Rühlemann, Manja Koch, et al.
Gastroenterology|July 23, 2022
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic PancreatitisUjjwal M Mahajan, Bettina Oehrle, Simon Sirtl, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 7, 2020
International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic ClubWilliam Greenhalf, Philippe Lévy, Thomas Gress, et al.
JAMA|July 12, 2012
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trialJohn P Neoptolemos, Malcolm J Moore, Trevor F Cox, et al.
The American Journal of Gastroenterology|April 22, 2010
Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory processJ-Matthias Löhr, Ralf Faissner, Dirk Koczan, et al.
Gut|December 13, 2012
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysisPhil A Hart, Terumi Kamisawa, William R Brugge, et al.
BMC Gastroenterology|January 17, 2013
Pre-study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitisGabriele Fluhr, Julia Mayerle, Eckhard Weber, et al.
Scientific Reports|January 30, 2019
Variants in ABCG8 and TRAF3 genes confer risk for gallstone disease in admixed Latinos with Mapuche Native American ancestryBernabé I Bustos, Eduardo Pérez-Palma, Stephan Buch, et al.
Cancers|November 27, 2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNAKaren Aughton, Nils O Elander, Anthony Evans, et al.
International Journal of Cancer|August 22, 2012
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinomaAlexander Baraniskin, Stefanie Nöpel-Dünnebacke, Maike Ahrens, et al.
Pageof 64